Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curative Biotechnology Inc (OP: CUBT )

0.0152 +0.0016 (+11.76%)
Streaming Delayed Price Updated: 10:47 AM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 101,000
Open 0.0137
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0136
Today's Range 0.0137 - 0.0152
52wk Range 0.0013 - 0.0400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
From Curative Biotechnology, Inc. 
Via GlobeNewswire
Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration
Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration National Eye Institute (NEI) to... 
Via iCrowdNewswire

Performance

YTD
-39.44%
-39.44%
1 Month
+11.76%
+11.76%
3 Month
+4.11%
+4.11%
6 Month
-47.59%
-47.59%
1 Year
+32.17%
+32.17%

More News

Read More
CURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO
Via iCrowdNewswire
Exposures COVID-19
CURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINE
Via iCrowdNewswire
Exposures COVID-19
Curative Biotechnology, Inc. Names Marc Drimer, CPA to Board of Directors
Via iCrowdNewswire
Curative Biotechnology, Inc. Announces Ticker Symbol Change to “CUBT” on OTC Markets
Via iCrowdNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.